But Inovio’s third-quarter sales came up short in November. Inovio stock traded below 10 per share in December. The company has a pipeline of drugs in development for cancer and infectious diseases.
Similarly, Who owns Inovio Pharmaceuticals?
Top 10 Owners of Inovio Pharmaceuticals Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 7.05% | 15,637,463 |
| SSgA Funds Management, Inc. | 6.00% | 13,300,430 |
| The Vanguard Group, Inc. | 4.83% | 10,703,079 |
| D. E. Shaw & Co. LP | 2.70% | 5,985,533 |
Does inovio have a Covid vaccine? INOVIO Receives U.S. FDA Authorization to Proceed with INNOVATE Phase 3 Segment for its COVID-19 Vaccine Candidate, INO-4800, in the U.S. PLYMOUTH MEETING, Pa., Nov.
Thereof, Does Inovio stock rebound?
Only through solid data and a solid plan to bring its vaccine candidate to market. At that point, Inovio stock may rebound.
How many shares does Ino have?
Share Statistics
| Avg Vol (3 month) 3 | 4.81M |
|---|---|
| Shares Outstanding 5 | 221.78M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 213.69M |
| % Held by Insiders 1 | 1.71% |
Who owns Nvax?
Top 10 Owners of Novavax Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 8.98% | 6,787,173 |
| BlackRock Fund Advisors | 4.70% | 3,549,765 |
| RA Capital Management LP | 2.78% | 2,097,794 |
| SSgA Funds Management, Inc. | 2.51% | 1,899,220 |
How old is INOVIO?
Inovio Pharmaceuticals Inc (NASDAQ:INO)
Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
What type of vaccine is INOVIO?
INO-4800, INOVIO’s DNA vaccine candidate against SARS-CoV-2, is composed of a precisely designed DNA plasmid that is injected intradermally followed by electroporation using a proprietary smart device, which delivers the DNA plasmid directly into cells in the body and is intended to produce a well-tolerated immune …
How effective is the INOVIO vaccine?
In a recently published paper in Lancet Infectious Diseases, INOVIO’s Phase 1 study of its MERS-CoV vaccine demonstrated it was well tolerated and furthermore induced high levels of antibody responses in roughly 95% of study participants.
Why did Inovio stock go up?
This can be attributed to delays in trials for INO-4800, the company’s Covid-19 vaccine candidate. INO stock rallied back to levels of $10 in June before falling again to levels of around $7 currently, and much of this volatility this year can be attributed to the developments around its Covid-19 vaccine.
What is Nvax new price target?
Stock Price Target NVAX
| High | $ 250.00 |
|---|---|
| Median | $ 193.50 |
| Low | $ 150.00 |
| Average | $ 196.00 |
| Current Price | $ 58.55 |
Who is Vanguard owned by?
Vanguard is owned by the funds managed by the company and is therefore owned by its customers. Vanguard offers two classes of most of its funds: investor shares and admiral shares.
…
The Vanguard Group.
| Type | Privately held company |
|---|---|
| Website | www.vanguard.com |
Does Vanguard own Novavax?
2022-02-10 – Vanguard Group Inc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,897,007 shares of Novavax, Inc. (US:NVAX). This represents 9.12 percent ownership of the company.
Who is the founder of Ino?
Charlie Maddock – Co-Founder – I N O | LinkedIn.
How does inovio Covid vaccine work?
INOVIO claims that administration with the CELLECTRA device ensures that the DNA medicine is efficiently delivered directly into the body’s cells, where it can go to work to drive an immune response.
What is DNA plasmid vaccine?
Plasmid-based DNA vaccines are a novel, economic, and effective strategy which induces antigen-specific immunity capable of conferring effective protection against various infectious diseases and tumor cells.
How does INOVIO Covid vaccine work?
INOVIO claims that administration with the CELLECTRA device ensures that the DNA medicine is efficiently delivered directly into the body’s cells, where it can go to work to drive an immune response.
What is Cellectra device?
PROPRIETARY SMART DEVICES (CELLECTRA®)
The CELLECTRA device uses a brief electrical pulse to reversibly open small pores in the cell to allow the plasmids to enter, overcoming a key limitation of other DNA and other nucleic acid approaches, such as mRNA.
What is the first DNA Covid vaccine?
The ZyCoV-D is the world’s first and India’s indigenously developed DNA based vaccine for COVID-19 to be administered in humans including children and adults 12 years and above.
What is Nvda target price?
The shares of NVIDIA Corporation (NASDAQ: NVDA) have received a $280 price target from New Street.
What is the hottest stock to buy right now?
Most Actives
| Company | Price | % Change |
|---|---|---|
| BAC Bank of America Corp | 38.80 | -0.96% |
| JPM JPMorgan Chase & Co | 127.03 | -3.43% |
| XOM Exxon Mobil Corp | 86.64 | +1.21% |
| OXY Occidental Petroleum Corp | 59.54 | +0.68% |
What is Nio price target?
The 29 analysts offering 12-month price forecasts for NIO Inc have a median target of 32.94, with a high estimate of 86.57 and a low estimate of 24.08. The median estimate represents a +67.62% increase from the last price of 19.65.
Join TheMoney.co community and don’t forget to share this post !
